HUT62033A - Process for producing human ciliary body neuronotropic factor - Google Patents

Process for producing human ciliary body neuronotropic factor

Info

Publication number
HUT62033A
HUT62033A HU91840A HU84091A HUT62033A HU T62033 A HUT62033 A HU T62033A HU 91840 A HU91840 A HU 91840A HU 84091 A HU84091 A HU 84091A HU T62033 A HUT62033 A HU T62033A
Authority
HU
Hungary
Prior art keywords
neuronotropic
factor
ciliary body
producing human
human ciliary
Prior art date
Application number
HU91840A
Other languages
English (en)
Other versions
HU910840D0 (en
Inventor
Francesco Della-Valle
Lanfranco Callegaro
Allesandro Negro
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4155790A external-priority patent/IT1239272B/it
Priority claimed from IT04165590A external-priority patent/IT1243286B/it
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of HU910840D0 publication Critical patent/HU910840D0/hu
Publication of HUT62033A publication Critical patent/HUT62033A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
HU91840A 1990-03-14 1991-03-14 Process for producing human ciliary body neuronotropic factor HUT62033A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4155790A IT1239272B (it) 1990-03-14 1990-03-14 Processo per l'isolamento di un segmento di dna che codifica il fattore neuronotrofico ciliare umano
IT04165590A IT1243286B (it) 1990-07-17 1990-07-17 Processo per isolamento ed espressione del fattore neuronotrofico ciliare umano mediante la tecnologia del dna ricombinante.

Publications (2)

Publication Number Publication Date
HU910840D0 HU910840D0 (en) 1991-09-30
HUT62033A true HUT62033A (en) 1993-03-29

Family

ID=26329124

Family Applications (1)

Application Number Title Priority Date Filing Date
HU91840A HUT62033A (en) 1990-03-14 1991-03-14 Process for producing human ciliary body neuronotropic factor

Country Status (11)

Country Link
EP (1) EP0446931A1 (hu)
JP (1) JPH04218374A (hu)
KR (1) KR910016921A (hu)
CN (1) CN1057295A (hu)
AR (1) AR243237A1 (hu)
AU (1) AU7291891A (hu)
CA (1) CA2038208A1 (hu)
HU (1) HUT62033A (hu)
IL (1) IL97557A0 (hu)
NO (1) NO911025L (hu)
PL (1) PL289413A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
IL98304A (en) * 1990-06-01 2008-08-07 Regeneron Pharma The ciliary neurotrophic factor receptor
IT1247150B (it) * 1991-01-21 1994-12-12 Fidia Spa Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.
CA2113815A1 (en) * 1991-07-23 1993-02-04 Franklin D. Collins Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage
EP0668911A1 (en) * 1991-11-11 1995-08-30 FIDIA S.p.A. Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
US5349056A (en) * 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors
US6472178B1 (en) 1998-02-27 2002-10-29 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
WO1998013024A2 (en) * 1996-09-27 1998-04-02 Hyal Pharmaceutical Corporation Hyaluronic drug delivery system
US6680291B1 (en) 1998-02-27 2004-01-20 Regeneron Pharmaceuticals, Inc. Modified ciliary neurotrophic factor, method of making and methods of use thereof
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor

Also Published As

Publication number Publication date
NO911025D0 (no) 1991-03-14
CA2038208A1 (en) 1991-09-15
NO911025L (no) 1991-09-16
CN1057295A (zh) 1991-12-25
AU7291891A (en) 1991-09-19
KR910016921A (ko) 1991-11-05
AR243237A1 (es) 1993-07-30
HU910840D0 (en) 1991-09-30
PL289413A1 (en) 1992-02-24
EP0446931A1 (en) 1991-09-18
JPH04218374A (ja) 1992-08-07
IL97557A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
GB2222954B (en) Tubular implant and process for the production thereof
EP0548365A4 (en) Process for producing implant
HUT61600A (en) Process for producing l-triptophane
CS4592A3 (en) Process for producing cellulose shaped body
HU904924D0 (en) Process for producing derivatives of human trombomoduline
HUT59725A (en) Process for producing human rutenleukine-5-receptor
HUT46705A (en) Process for producing christalline human proinsuline
HUT62033A (en) Process for producing human ciliary body neuronotropic factor
EP0476528A3 (en) Process for producing stable latex
HUT50505A (en) Process for producing recombinante human interleukin-1-alpha-polypeptides
HUT59695A (en) Process for producing hydroxy-ethyl-amine- and norstai
ZA914435B (en) Treatment of disease
HUT58699A (en) Process for producing 2-chloro-5-methyl-pyridine
GB8925066D0 (en) Continuous treatment process
CS323891A3 (en) Column-like body and process for producing thereof
HU910578D0 (en) Process for producing 4-hydroxiphenethyl-alcohol
HU910745D0 (en) Process for producing 1-treonine
HUT61530A (en) Process for producing 1-hydroxyalkyl-5-nitroimidazoles
HUT60239A (en) Process for producing glian
GB9118975D0 (en) Process for producing a hollow fibre-composite body
GB2241958B (en) Treatment process
GB2267705B (en) Process for producing 2-alkyl-4-halo-5-formylimidazoles
GB9005448D0 (en) Treatment process
HU900381D0 (en) Process for producing medical preparatives utilizable for treating cancerous diseases
HU207656B (en) Process for producing cheloide creme

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee